- Home
- HURN vs ARWR Comparison
HURN vs ARWR Comparison
Compare HURN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURN
- ARWR
- Stock Information
- Founded
- HURN 2002
- ARWR 2003
- Country
- HURN United States
- ARWR United States
- Employees
- HURN N/A
- ARWR N/A
- Industry
- HURN Professional Services
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- HURN Consumer Discretionary
- ARWR Health Care
- Exchange
- HURN Nasdaq
- ARWR Nasdaq
- Market Cap
- HURN 2.4B
- ARWR 2.5B
- IPO Year
- HURN 2004
- ARWR 1993
- Fundamental
- Price
- HURN $140.70
- ARWR $29.72
- Analyst Decision
- HURN Strong Buy
- ARWR Strong Buy
- Analyst Count
- HURN 4
- ARWR 8
- Target Price
- HURN $171.50
- ARWR $47.75
- AVG Volume (30 Days)
- HURN 188.7K
- ARWR 2.9M
- Earning Date
- HURN 10-28-2025
- ARWR 08-07-2025
- Dividend Yield
- HURN N/A
- ARWR N/A
- EPS Growth
- HURN 37.96
- ARWR N/A
- EPS
- HURN 5.74
- ARWR N/A
- Revenue
- HURN $1,556,665,000.00
- ARWR $572,976,000.00
- Revenue This Year
- HURN $13.32
- ARWR $22,306.37
- Revenue Next Year
- HURN $8.31
- ARWR N/A
- P/E Ratio
- HURN $24.59
- ARWR N/A
- Revenue Growth
- HURN 9.24
- ARWR 2816.20
- 52 Week Low
- HURN $102.95
- ARWR $9.57
- 52 Week High
- HURN $155.00
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- HURN 55.79
- ARWR 76.98
- Support Level
- HURN $135.79
- ARWR $27.10
- Resistance Level
- HURN $142.26
- ARWR $29.34
- Average True Range (ATR)
- HURN 3.81
- ARWR 1.47
- MACD
- HURN 0.17
- ARWR 0.47
- Stochastic Oscillator
- HURN 50.08
- ARWR 86.89
About HURN Huron Consulting Group Inc.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.